154 related articles for article (PubMed ID: 17368033)
1. 2D-autocorrelation descriptors for predicting cytotoxicity of naphthoquinone ester derivatives against oral human epidermoid carcinoma.
Saíz-Urra L; González MP; Teijeira M
Bioorg Med Chem; 2007 May; 15(10):3565-71. PubMed ID: 17368033
[TBL] [Abstract][Full Text] [Related]
2. QSAR studies about cytotoxicity of benzophenazines with dual inhibition toward both topoisomerases I and II: 3D-MoRSE descriptors and statistical considerations about variable selection.
Saíz-Urra L; González MP; Teijeira M
Bioorg Med Chem; 2006 Nov; 14(21):7347-58. PubMed ID: 16962784
[TBL] [Abstract][Full Text] [Related]
3. BCUT descriptors to predicting affinity toward A3 adenosine receptors.
González MP; Terán C; Teijeira M; Besada P; González-Moa MJ
Bioorg Med Chem Lett; 2005 Aug; 15(15):3491-5. PubMed ID: 15990306
[TBL] [Abstract][Full Text] [Related]
4. Radial distribution function descriptors: an alternative for predicting A2 A adenosine receptors agonists.
González MP; Terán C; Teijeira M; Helguera AM
Eur J Med Chem; 2006 Jan; 41(1):56-62. PubMed ID: 16253394
[TBL] [Abstract][Full Text] [Related]
5. Estimation of relationship between descriptors and cytotoxicity of newly synthesized 1,2,3,4-tetrahydroisoquinoline derivatives.
Ishihara M; Hatano H; Takekawa F; Kawase M; Sakagami H
Anticancer Res; 2009 Oct; 29(10):4077-82. PubMed ID: 19846954
[TBL] [Abstract][Full Text] [Related]
6. Geometry, topology, and atom-weights assembly descriptors to predicting A1 adenosine receptors agonists.
González MP; Terán C; Teijeira M; Besada P
Bioorg Med Chem Lett; 2005 May; 15(10):2641-5. PubMed ID: 15863334
[TBL] [Abstract][Full Text] [Related]
7. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
Nandi S; Vracko M; Bagchi MC
Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel rhinacanthins and related anticancer naphthoquinone esters.
Kongkathip N; Luangkamin S; Kongkathip B; Sangma C; Grigg R; Kongsaeree P; Prabpai S; Pradidphol N; Piyaviriyagul S; Siripong P
J Med Chem; 2004 Aug; 47(18):4427-38. PubMed ID: 15317455
[TBL] [Abstract][Full Text] [Related]
9. Quantitative structure-activity relationship (QSAR) analysis of tumor-specificity of 1,2,3,4-tetrahydroisoquinoline derivatives.
Uesawa Y; Mohri K; Kawase M; Ishihara M; Sakagami H
Anticancer Res; 2011 Dec; 31(12):4231-8. PubMed ID: 22199286
[TBL] [Abstract][Full Text] [Related]
10. A TOPological Sub-structural Molecular Design (TOPS-MODE)-QSAR approach for modeling the antiproliferative activity against murine leukemia tumor cell line (L1210).
Molina-Ruiz R; Saíz-Urra L; Rodríguez-Borges JE; Pérez-Castillo Y; González MP; García-Mera X; Cordeiro MN
Bioorg Med Chem; 2009 Jan; 17(2):537-47. PubMed ID: 19114309
[TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationship studies of HIV-1 integrase inhibition. 1. GETAWAY descriptors.
Saíz-Urra L; González MP; Fall Y; Gómez G
Eur J Med Chem; 2007 Jan; 42(1):64-70. PubMed ID: 17030481
[TBL] [Abstract][Full Text] [Related]
12. Design and QSAR study of analogs of gamma-tocotrienol with enhanced antiproliferative activity against human breast cancer cells.
Nikolic K; Agababa D
J Mol Graph Model; 2009 Apr; 27(7):777-83. PubMed ID: 19117779
[TBL] [Abstract][Full Text] [Related]
13. CP-MLR directed QSAR studies on the antimycobacterial activity of functionalized alkenols--topological descriptors in modeling the activity.
Gupta MK; Sagar R; Shaw AK; Prabhakar YS
Bioorg Med Chem; 2005 Jan; 13(2):343-51. PubMed ID: 15598557
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticancer evaluation of naphthoquinone esters with 2'-cyclopentyl and 2'-cyclohexyl substituents.
Kongkathip N; Pradidphol N; Hasitapan K; Kongkathip B
Biosci Biotechnol Biochem; 2010; 74(6):1205-14. PubMed ID: 20530913
[TBL] [Abstract][Full Text] [Related]
15. Halogenated derivatives QSAR model using spectral moments to predict haloacetic acids (HAA) mutagenicity.
Pérez-Garrido A; González MP; Escudero AG
Bioorg Med Chem; 2008 May; 16(10):5720-32. PubMed ID: 18406150
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
[TBL] [Abstract][Full Text] [Related]
17. Proteochemometric modeling of the inhibition complexes of matrix metalloproteinases with N-hydroxy-2-[(phenylsulfonyl)amino]acetamide derivatives using topological autocorrelation interaction matrix and model ensemble averaging.
Fernández M; Fernández L; Caballero J; Abreu JI; Reyes G
Chem Biol Drug Des; 2008 Jul; 72(1):65-78. PubMed ID: 18554254
[TBL] [Abstract][Full Text] [Related]
18. Quantitative structure activity relationship of benzoxazinone derivatives as neuropeptide Y Y5 receptor antagonists.
Deswal S; Roy N
Eur J Med Chem; 2006 Apr; 41(4):552-7. PubMed ID: 16545499
[TBL] [Abstract][Full Text] [Related]
19. QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.
Fernández M; Caballero J
Bioorg Med Chem; 2007 Sep; 15(18):6298-310. PubMed ID: 17590339
[TBL] [Abstract][Full Text] [Related]
20. A TOPS-MODE approach to predict adenosine kinase inhibition.
González MP; Moldes del Carmen Terán M
Bioorg Med Chem Lett; 2004 Jun; 14(12):3077-9. PubMed ID: 15149648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
